Characterization of the phase transitions of trehalose dihydrate on heating and subsequent dehydration

Journal of Pharmaceutical Sciences
L S Taylor, P York

Abstract

Many pharmaceutical compounds of interest form hydrates. The phase behavior of different particle size fractions of trehalose dihydrate was studied as the sugar was dehydrated by heating. Hot-stage microscopy, X-ray powder diffraction, thermogravimetric analysis, and differential scanning calorimetry were used to characterize the phase changes. Small particles (<45 microm) formed an amorphous phase on dehydration and subsequently liquefied at temperatures above the glass transition temperature of amorphous trehalose. Crystallization to the anhydrate was observed from this supercooled liquid. Large particles (>425 microm) underwent a solid-solid conversion from the dihydrate to the anhydrate at temperatures as low as 80 degrees C. This solid-solid conversion was explained by a catalytic effect of the liberated dihydrate water on the rearrangement of the dehydrated phase to the anhydrate. The large surface area-to-volume ratio of the small particles resulted in dehydration prior to attaining the threshold temperature for rearrangement, explaining why solid-solid conversion was absent for these particles.

References

Mar 29, 1985·Carbohydrate Research·G A Jeffrey, R Nanni
Mar 1, 1970·The Journal of Pharmacy and Pharmacology·J T Fell, J M Newton
Mar 1, 1995·Journal of Pharmaceutical Sciences·A Saleki-GerhardtG Zografi
Aug 1, 1994·Pharmaceutical Research·A Saleki-Gerhardt, G Zografi
Oct 1, 1996·Biophysical Journal·L M CroweJ H Crowe
Jan 1, 1997·Journal of Pharmaceutical Sciences·B C Hancock, G Zografi
Aug 1, 1963·Journal of Pharmaceutical Sciences·E SHEFTER, T HIGUCHI
Sep 1, 1962·Canadian Journal of Biochemistry and Physiology·H J REISENERA S PERLIN

❮ Previous
Next ❯

Citations

Aug 24, 2006·Pharmaceutical Research·Meena RaniRaj Suryanarayanan
Apr 9, 2005·International Journal of Pharmaceutics·M HorvatD Q M Craig
Apr 22, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M ChacónM R Aberturas
Nov 26, 2009·AAPS PharmSciTech·Paroma ChakravartyRaj Suryanarayanan
Sep 2, 2011·Chemical & Pharmaceutical Bulletin·Anita HafnerJelena Filipović-Grčić
Sep 4, 2013·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Charles J WhiteMark E Byrne
Apr 16, 2005·Drug Development and Industrial Pharmacy·M LandínR Martínez-Pacheco
May 21, 2009·Journal of Pharmaceutical Sciences·Alan D GiftLynne S Taylor
Sep 23, 2003·Journal of Pharmaceutical Sciences·Eetu RäsänenHeikki Vuorela
Mar 29, 2002·Journal of Pharmaceutical Sciences·Matti U A Ahlqvist, Lynne S Taylor
Nov 9, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·C J MartinJ C Birchall
Oct 27, 2009·Analytical Biochemistry·Brian ConnollyTim J Kamerzell
Nov 16, 2004·International Journal of Pharmaceutics·Tue HansenKirsten Schultz
Dec 13, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Natasa JovanovićWim Jiskoot
Jul 18, 2006·Nature Materials·Duncan KilburnJob Ubbink
Dec 4, 2019·Analytical Chemistry·Alex M ShermanGarth J Simpson
Jun 15, 2006·The Journal of Physical Chemistry. B·J F WillartM Descamps

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.